“Advances in the pharmacotherapy of Heart Failure: type 2 sodium-glucose cotransporter Inhibitors (SGLT2) as a therapeutic option”, RSD, vol. 12, no. 3, p. e12412340502, Mar. 2023, doi: 10.33448/rsd-v12i3.40502.